Search Results

Displaying Results 3901-3925 of 5703 "'MET'"

Feb 02, 2026, 08:00 ET Real-world head-to-head analysis shows 51% reduction in risk of death for patients with metastatic castration-sensitive prostate cancer treated with ERLEADA® (apalutamide) versus darolutamide without docetaxel through 24 months

darolutamide without docetaxel between August 2022 and June 2025. There were 1,460 ERLEADA® patients and 287 darolutamide initiators who met study criteria."These real-world data show the survival benefit of apalutamide versus darolutamide in patients with mCSPC without the concurrent

More news about: Johnson & Johnson


Feb 02, 2026, 05:55 ET Anniversary boost: Spielwarenmesse strengthens its global leadership

concrete market figures significantly enriched my trade fair conversations," says Polish publisher Dorota Mazurek. The Game Inventors Convention also met with great approval, with international games organizations represented for the first time. Mary Couzin from the Chicago Toy and Game Group was also

More news about: Spielwarenmesse eG


Feb 02, 2026, 05:50 ET Anniversary boost: Spielwarenmesse strengthens its global leadership

concrete market figures significantly enriched my trade fair conversations," says Polish publisher Dorota Mazurek. The Game Inventors Convention also met with great approval, with international games organizations represented for the first time. Mary Couzin from the Chicago Toy and Game Group was also

More news about: Spielwarenmesse eG


Feb 02, 2026, 04:42 ET Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - CORT

treatment for patients with hypertension secondary to hypercortisolism." The Company added, "the FDA acknowledged that Corcept's pivotal GRACE trial met its primary endpoint and that data from the company's GRADIENT trial provided confirmatory evidence, the Agency concluded it could not arrive at a favorable

More news about: DJS Law Group LLP


Feb 02, 2026, 04:41 ET CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm

treatment for patients with hypertension secondary to hypercortisolism." According to the Company, "the FDA acknowledged that Corcept's pivotal GRACE trial met its primary endpoint and that data from the company's GRADIENT trial provided confirmatory evidence, the Agency concluded it could not arrive at a favorable

More news about: The Schall Law Firm


Feb 02, 2026, 04:31 ET Wu Zuyu de Hithium invitado a reunirse con el primer ministro del Reino Unido

https://mma.prnewswire.com/media/2874152/UK_Prime_Minister_Keir_Starmer_met_Wu_Zuyu.jpgLogo - 

More news about: HiTHIUM


Feb 02, 2026, 04:04 ET Beko behaalt de eerste plek voor duurzame huishoudelijke producten in de Corporate Knights Global 100

blijven.Over BekoBeko is een internationaal bedrijf voor huishoudelijke apparaten met een sterke wereldwijde aanwezigheid, actief via dochterondernemingen in meer dan 55 landen met een personeelsbestand van meer dan 50.000 werknemers en productiefaciliteiten in meerdere regio's,

More news about: Beko


Feb 02, 2026, 03:40 ET La K-Beauty se met à la mode : COSRX fait ses débuts dans les coulisses de la Haute Couture auprès de MISS SOHEE

content:https://www.prnewswire.com/fr/communiques-de-presse/la-k-beauty-se-met-a-la-mode--cosrx-fait-ses-debuts-dans-les-coulisses-de-la-haute-couture-aupres-de-miss-sohee-302675680.html

More news about: COSRX


Feb 02, 2026, 02:11 ET Een eerste blik op AI in de echte wereld: AWE 2026 opent deze maart in Shanghai

(SNIEC) en het tentoonstellingsgebied van de Shanghai Eastern Hub International Business Cooperation Zone (Eastern Hub IBCZ). Met een oppervlakte van 170.000 vierkante meter, met meer dan 1200 merken en naar verwachting meer dan 200.000 bezoekers, De inschrijving voor AWE 2026 is nu wereldwijd geopend.

More news about: AWE


Feb 01, 2026, 23:18 ET Ping An Money Market Fund's 'AAAmf' Rating Affirmed by Lianhe Global

well managed asset quality, strong liquidity profile and low exposure to market risk.The credit quality of the Fund's underlying investments met Lianhe Global's criteria for 'AAAmf' rated MMFs, with asset-weighted average credit quality equivalent to a high-investment-grade international rating

More news about: PAAMC HK


Feb 01, 2026, 17:53 ET Wu Zuyu von Hithium zu einem Treffen mit dem britischen Premierminister eingeladen

https://mma.prnewswire.com/media/2874152/UK_Prime_Minister_Keir_Starmer_met_Wu_Zuyu.jpgLogo -

More news about: HiTHIUM


Feb 01, 2026, 17:46 ET Wu Zuyu de Hithium invité à rencontrer le premier ministre britannique

https://mma.prnewswire.com/media/2874152/UK_Prime_Minister_Keir_Starmer_met_Wu_Zuyu.jpgLogo -

More news about: HiTHIUM


Feb 01, 2026, 13:49 ET Wu Zuyu of Hithium Invited to Meet with UK Prime Minister

During the forum, UK Prime Minister Keir Starmer met with Wu Zuyu, and the two sides exchanged views on matters related to energy storage cooperation.On January 30, the UK government stated in a

More news about: HiTHIUM


Feb 01, 2026, 09:00 ET 25 Years and Counting: Church of the Highlands Marks a Milestone of Impact and Looks Ahead to the Future

February 4, 2001, Church of the Highlands was established on a commitment to prayer—a commitment that remains central 25 years later. Before the church met for its first Sunday, the launch team prayed for 21 days to set the foundation. Each year, the church continues this legacy by beginning with 21 Days

More news about: Church of the Highlands


Feb 01, 2026, 01:35 ET Aphranel lance sa stratégie de marque "La Poétique du Temps" à IMCAS Paris, redéfinissant ainsi la valeur à long terme de l'esthétique médicale

laquelle il vaut la peine d'investir.Dans ce cadre, Aphranel définit la valeur esthétique à travers trois dimensions. L'efficacité immédiate met l'accent sur un soutien structurel fiable et une amélioration initiale visible, grâce au matériau CaHA High-G' d'Aphranel. Evolving Vitality reflète

More news about: SHANGHAI MOYANG BIOTECHNOLOGY CO., LTD


Jan 31, 2026, 15:40 ET Bybit onthult 2026-visie als "The New Financial Platform" en breidt uit van cryptobeurs naar wereldwijde financiële infrastructuur

diensten te leveren die naadloos integreren met gereguleerde fiat-infrastructuur."Financiën mogen niet worden beperkt door geografie", zei Ben Zhou, medeoprichter en CEO van Bybit. "We bouwen financiële infrastructuur die cryptotoepassingen verbindt met economische activiteiten in de echte wereld.

More news about: Bybit


Jan 30, 2026, 19:00 ET DESERT FINANCIAL DONATES $1.425 MILLION TO PHOENIX CHILDREN'S 1 DARN COOL SCHOOL

Cool School: bringing structure, connection and familiar routines to children whose time is shaped by medical care. During his hospital stays, teachers met with Ramirez in a shared classroom space when he felt well enough or at his bedside when he didn't."It made me feel free because you could go

More news about: Desert Financial Credit Union


Jan 30, 2026, 17:00 ET BANKFIRST CAPITAL CORPORATION Reports Fourth Quarter and Year-End 2025 Earnings of $10.17 Million and $28.68 Million, respectively

consecutive Reset Dates, as defined pursuant to the Policy. The earliest possible date by which a Threshold Condition may be met is June 30, 2026. As of December 31, 2025, the Company has met the Qualified Lending Condition for the past 14 consecutive quarters. Assuming the Company continues to satisfy the Qualified

More news about: BankFirst Capital Corporation


Jan 30, 2026, 14:48 ET L'exposition du bureau et des espaces commerciaux du salon CIFF Guangzhou 2026 met en avant la transformation durable des environnements de travail

content:https://www.prnewswire.com/news-releases/lexposition-du-bureau-et-des-espaces-commerciaux-du-salon-ciff-guangzhou-2026-met-en-avant-la-transformation-durable-des-environnements-de-travail-302675363.html

More news about: China International Furniture Fair (Guangzhou)


Jan 30, 2026, 11:32 ET Lucid Air obtient la meilleure autonomie lors du NAF Winter Test 2026

président de Lucid pour l'Europe. « Ce test fournit des indications précieuses sur les performances des véhicules électriques dans le monde réel et met en évidence les progrès remarquables que nous avons accomplis dans le développement des véhicules électriques. Atteindre cet objectif dans des conditions

More news about: Lucid Group


Jan 30, 2026, 11:25 ET Unifi Aviation breidt uit naar continentaal Europa met de overname van Viggo

om mensen op de eerste plaats te zetten en uitzonderlijke service te bieden. Samen met Karan Ishwar, CEO, en Ernie Patterson, International Chairman  van de Argenbright Group kijk ik ernaar uit om nauw samen te werken met de directie van Viggo."  Viggo levert passagiers-, bagage- en platformafhandelingsdiensten

More news about: Unifi


Jan 30, 2026, 09:49 ET The Province of Córdoba Announces Amounts Tendered as of Expiration of Cash Tender Offer for its U.S. Dollar Step-Up Notes Due 2027

accepted Existing Notes will be entitled to receive for such Existing Notes the Purchase Price and Accrued Interest, if the conditions of the Offer are met.On February 2, 2026, subject to change without notice, the Province expects to announce: (i) its decision of whether to accept valid Tenders of

More news about: The Province of Córdoba


Jan 30, 2026, 09:45 ET CobbleStone Software Achieves FedRAMP Ready Status, Advances Authorization Efforts

assessment package for FedRAMP review.Achieving FedRAMP Ready status indicates that CobbleStone Software and CobbleStone Contract Insight have met the initial security documentation and system readiness requirements and are prepared to move forward in the authorization process. This designation

More news about: CobbleStone Software


Jan 30, 2026, 09:39 ET Lundbeck presents new real-world data highlighting meaningful improvements in patients severely impacted by migraine initiating Vyepti® (eptinezumab), at HCOP Annual Conference

evaluated in two Phase 3 clinical trials (PROMISE-1 in episodic migraine11 and PROMISE-2 in chronic migraine),12 where eptinezumab met its primary endpoint of decrease in monthly migraine days (MMDs) over weeks 1-12 in both episodic and chronic migraine.Furthermore, the clinical

More news about: H. Lundbeck A/S


Jan 30, 2026, 09:35 ET Lundbeck presents new real-world data highlighting meaningful improvements in patients severely impacted by migraine initiating Vyepti® (eptinezumab), at HCOP Annual Conference

evaluated in two Phase 3 clinical trials (PROMISE-1 in episodic migraine11 and PROMISE-2 in chronic migraine),12 where eptinezumab met its primary endpoint of decrease in monthly migraine days (MMDs) over weeks 1-12 in both episodic and chronic migraine.Furthermore, the clinical

More news about: H. Lundbeck A/S


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.